Antioxidant N-acetyl cysteine reverses cigarette smoke-induced myocardial infarction by inhibiting inflammation and oxidative stress in a rat model

Laboratory Investigation

Volumn 92, Issue 2, 2012, Pages 224-235

  Khanna, Ashwani K ^a,b   Xu, Jianping ^c   Mehra, Mandeep R ^a,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b OncoDetect   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

Author keywords

antioxidants; cardiac dysfunction; cigarette smoke; myocardial infarction; Nrf2

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; CIGARETTE SMOKE; CYTOKINE; GLUTATHIONE; MESSENGER RNA; SUPEROXIDE DISMUTASE; THIOREDOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; CYTOKINE PRODUCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE NECROSIS; INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TRANSCRIPTOMICS;

EID: 84863028079     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2011.146     Document Type: Article

References (55)

1. Khanna A, Xu J, Uber P, et al. Pre-transplant donor or recipient tobacco smoke exposure accelerates cardiac allograft rejection, vasculopathy and graft loss. Circulation 2009;120:1814-1821.
2. Tomaki M, Sugiura H, Koarai A, et al. Decreased expression of antioxidant enzymes and increased expression of chemokines in COPD lung. Pulm Pharmacol Ther 2007;20:596-605. (Pubitemid 47077652)
3. Mendall MA, Patel P, Ballam L, et al. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 1996;312:1061-1065. (Pubitemid 26125131)
4. Tracy RP, Psaty BM, Macy E, et al. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arteriosclerosis Thromb Vasc Biol 1997;17:2167-2176. (Pubitemid 28057118)
5. Hasday JD, Bascom R, Costa JJ, et al. Bacterial endotoxin is an active component of cigarette smoke. Chest 1999;115:829-835. (Pubitemid 29129968)
6. Churg A, Wang RD, Tai H, et al. Macrophage metalloelastase mediates acute cigarette smoke-induced inflammation via tumor necrosis factor-alpha release. Am J Respir Crit Care Med 2003;167:1083-1089. (Pubitemid 36459653)
7. Foronjy RFO, Propokenko O, Lemaitre V, et al. Superoxide dismutase expression attenuates cigarette smoke- or elastase-generated emphysema in mice. Am J Resp Crit Care Med 2006;173:623-631. (Pubitemid 43363803)
8. Kato T, Inoue T, Morooka T, et al. Short-term passive smoking causes endothelial dysfunction via oxidative stress in nonsmokers. Can J Physiol Pharmacol 2006;84:523-529. (Pubitemid 44350526)
9. Aycicek A, Erel O, Kocyigit A. Decreased total antioxidant capacity and increased oxidative stress in passive smoker infants and their mothers. Pediatr Int 2005;47:635-639. (Pubitemid 43951543)
10. Iizuka T, Ishii Y, Itoh K, et al. Nrf2-deficient mice are highly susceptible to cigarette smoke-induced emphysema. Genes Cells 2005;10:1113-1125. (Pubitemid 41830071)
11. Sobczak A, Golka D, Szoltysek-Boldys I. The effects of tobacco smoke on plasma alpha- and gamma-tocopherol levels in passive and active cigarette smokers. Toxicol Lett 2004;151:429-437. (Pubitemid 38925318)
12. Harman SM, Liang L, Tsitouras PD, et al. Urinary excretion of three nucleic acid oxidation adducts and isoprostane F(2)alpha measured by liquid chromatography-mass spectrometry in smokers, ex-smokers, and nonsmokers. Free Radic Biol Med 2003;15:1301-1309. (Pubitemid 37357255)
13. Koul A, Singh A, Sandhir R. Effect of alpha-tocopherol on the cardiac antioxidant defense system and atherogenic lipids in cigarette smokeinhaling mice. Inhal Toxicol 2003;15:513-522. (Pubitemid 36596920)
14. Wang S, Sun NN, Zhang J, et al. Immunomodulatory effects of highdose alpha-tocopherol acetate on mice subjected to sidestream cigarette smoke. Toxicology 2002;175:235-245. (Pubitemid 34615717)
15. Szocs K, Lassègue B, Sorescu D, et al. Upregulation of Nox-based NAD(P)H oxidases in restenosis after carotid injury. Arterioscler Thromb Vasc Biol 2002;22:21-22.
16. Penna C, Mancardi D, Rastaldo R, et al. Cardioprotection: a radical view free radicals in pre and postconditioning. Biochim Biophys Acta 2009;1787:781-793.
17. Looi YH, Grieve DJ, Siva A, et al. Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction. Hypertension 2008;51:319-325. (Pubitemid 351159945)
18. Sirker A, Zhang M, Murdoch C, et al. Involvement of NADPH oxidases in cardiac remodelling and heart failure. Am J Nephrol 2007;27:649-660. (Pubitemid 350014953)
19. Zhao L, Roche BM, Wessale JL, et al. Chronic xanthine oxidase inhibition following myocardial infarction in rabbits: effects of early versus delayed treatment. Life Sci 2008;82:495-502.
20. Doerries CK, Hilfiker-Kleiner D, Luchtefeld M, et al. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction. Circ Res 2007;100:894-903. (Pubitemid 46555695)
21. Qin F, Simeone M, Patel R. Inhibition of NADPH oxidase reduces myocardial oxidative stress and apoptosis and improves cardiac function in heart failure after myocardial infarction. Free Radic Biol Med 2007;43:271-281. (Pubitemid 46977168)
22. Chen Z, Siu B, Ho YS, et al. Overexpression of MnSOD protects against myocardial ischemia/reperfusion injury in transgenic mice. J Mol Cell Cardiol 1998;30:2281-2289. (Pubitemid 28549980)
23. Wang P, Chen H, Qin H, et al. Overexpression of human copper, zincsuperoxide dismutase (SOD1) prevents postischemic injury. Proc Natl Acad Sci USA 1998;95:4556-4560. (Pubitemid 28207951)
24. Date MO, Morita T, Yamashita N, et al. The antioxidant N-2- mercaptopropionyl glycine attenuates left ventricular hypertrophy in in vivo murine pressure-overload model. J Am Coll Cardiol 2002;39:907-912. (Pubitemid 34185342)
25. Tsujimoto I, Hikoso S, Yamaguchi O, et al. The antioxidant edaravone attenuates pressure overload-induced left ventricular hypertrophy. Hypertension 2005;45:921-926. (Pubitemid 40628938)
26. Oskarsson HJ, Coppey L, Weiss RM, et al. Antioxidants attenuate myocyte apoptosis in the remote non-infarcted myocardium following large myocardial infarction. Cardiovasc Res 2000;45:679-687. (Pubitemid 30047134)
27. Sia YT, Parker TG, Liu P, et al. Improved post-myocardial infarction survival with probucol in rats: effects on left ventricular function, morphology, cardiac oxidative stress and cytokine expression. J Am Coll Cardiol 2002;39:148-156. (Pubitemid 34059875)
28. Siveski-Iliskovic N, Kaul N, Singal PK. Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats. Circulation 1994;89:2829-2835. (Pubitemid 24173705)
29. Nakamura R, Egashira K, Machida Y, et al. Probucol attenuates left ventricular dysfunction and remodeling in tachycardia-induced heart failure: roles of oxidative stress and inflammation. Circulation 2002;106:362-367. (Pubitemid 34778962)
30. Betge S, Lutz K, Roskos M, et al. Oral treatment with probucol in a pharmacological dose has no beneficial effects on mortality in chronic ischemic heart failure after large myocardial infarction in rats. Eur J Pharmacol 2007;558:119-127. (Pubitemid 46328875)
31. Hoshida S, Yamashita N, Igarashi J, et al. Long-term probucol treatment reverses the severity of myocardial injury in watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb Vasc Biol 1997;17:2801-2807. (Pubitemid 28016024)
32. Xu L, Cai BQ, Zhu YJ. Pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease and therapeutic effects of glucocorticoids and N-acetylcysteine in rats. Chin Med J (Engl) 2004;117:1611-1619. (Pubitemid 39619234)
33. Xu J, Zhang C, Khanna A. Wideband high frequency echocardiography to evaluate myocardial infarct size. J Ultrasound Med 2009;28:1501-1509.
34. Gu L, Pandey V, Geenen DL, et al. Cigarette smoke-induced left ventricular remodelling is associated with activation of mitogenactivated protein kinases. Eur J Heart Fail 2008;10:1057-1064.
35. Castardeli E, Duarte DR, Minicucci MF, et al. Tobacco smoke-induces left ventricular remodeling is not associated with metalloproteinase-2 or -9 activation. Eur J Heart Fail 2007;9:1081-1085. (Pubitemid 47633318)
36. Castardeli E, Paiva SA, Matsubara BB, et al. Chronic cigarette smoke exposure results in cardiac remodeling and impaired ventricular function in rats. Arq Bras Cardiol 2005;84:320-324. (Pubitemid 40695340)
37. Chandrasekar B, Colston JT, Freeman GL. Induction of proinflammatory cytokine and antioxidant enzyme gene expression following brief myocardial ischaemia. Clin Exp Immunol 1997;108:346-351. (Pubitemid 27223477)
38. Debrunner M, Schuiki E, Minder E, et al. Proinflammatory cytokines in acute myocardial infarction with and without cardiogenic shock. Clin Res Cardiol 2008;97:298-305. (Pubitemid 351725055)
39. Samnega°rd A, Hulthe J, Silveira A, et al. Gender specific associations between matrix metalloproteinases and inflammatory markers in post myocardial infarction patients. Atherosclerosis 2009;202:550-556.
40. Kelishadi R, Sabri M, Motamedi N, et al. Factor analysis of markers of inflammation and oxidation and echocardiographic findings in children with a positive family history of premature coronary heart disease. Pediatr Cardiol 2009;30:477-481.
41. Orn S, Manhenke C, Ueland T, et al. C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction. Eur Heart J 2009;30:1180-1186.
42. Schulz R, Heusch G. Tumor necrosis factor-alpha and its receptors 1 and 2: Yin and Yang in myocardial infarction? Circulation 2009 119 1355-1357.
43. Zingarelli B, Hake PW, O'Connor M, et al. Differential regulation of activator protein-1 and heat shock factor-1 in myocardial ischemia and reperfusion injury: role of poly(ADP-ribose) polymerase-1. Am J Physiol Heart Circ Physiol 2004;286:H1408-H1415. (Pubitemid 38381149)
44. Palfi A, Toth A, Hanto K, et al. PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway. J Mol Cell Cardiol 2006;41:149-159. (Pubitemid 43946965)
45. Zalba G, San JoséG, Moreno MU, et al. NADPH oxidase-mediated oxidative stress: genetic studies of the p22 (phox) gene in hypertension. Antioxid Redox Signal 2005;7:1327-1336.
46. Kou B, Zhang J, Singer DR. Effects of cyclic strain on endothelial cell apoptosis and tubulogenesis are dependent on ROS production via NAD(P)H subunit p22phox. Microvasc Res 2009;77:125-133.
47. Manea A, Manea SA, Gafencu AV, et al. AP-1-dependent transcriptional regulation of NADPH oxidase in human aortic smooth muscle cells: role of p22phox subunit. Arterioscler Thromb Vasc Biol 2008;28:878-885. (Pubitemid 351544102)
48. Kawahara T, Ritsick D, Cheng G, et al. Point mutations in the proline-rich region of p22phox are dominant inhibitors of Nox1- and Nox2-dependent reactive oxygen generation. J Biol Chem 2005; 280:31859-31869. (Pubitemid 41291936)
49. Modlinger P, Chabrashvili T, Gill PS, et al. RNA silencing in vivo reveals role of p22phox in rat angiotensin slow pressor response. Hypertension 2006;47:238-244. (Pubitemid 43189769)
50. Zhang DD. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab Rev 2006;38:769-789. (Pubitemid 44903268)
51. Nguyen T, Nioi P, Pickett CB. The Nrf2-ARE signaling pathway and its activation by oxidative stress. J Biol Chem 2009;284:13291-13295.
52. Mann GE, Bonacasa B, Ishii T, et al. Targeting the redox sensitive Nrf2- Keap1 defense pathway in cardiovascular disease: protection afforded by dietary isoflavones. Curr Opin Pharmacol 2009;9:139-145.
53. Levonen AL, Landar A, Ramachandran A, et al. Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defenses in response to electrophilic lipid oxidation products. Biochem J 2004;378:373-382. (Pubitemid 38367228)
54. Hübner RH, Schwartz JD, De Bishnu P, et al. Coordinate control of expression of Nrf2-modulated genes in the human small airway epithelium is highly responsive to cigarette smoking. Mol Med 2009;15:203-219.
55. Knörr-Wittmann C, Hengstermann A, Gebel S, et al. Characterization of Nrf2 activation and heme oxygenase-1 expression in NIH3T3 cells exposed to aqueous extracts of cigarette smoke. Free Radic Biol Med 2005;39:1438-1448. (Pubitemid 41547224)